Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (12)

2024

  1. Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: Study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study)

    BMJ Open, Vol. 14, Núm. 9

2022

  1. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal

2017

  1. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

  2. Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine

    Nature, Vol. 546, Núm. 7660, pp. 676-680

2015

  1. Análisis del patrón epidemiológico de la shigelosis en Barcelona entre 1988 y 2012: ¿es una infección de transmisión sexual emergente?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 33, Núm. 6, pp. 379-384

  2. Semen quality assessment in fertile men in madrid during the last 3 decades

    Urology, Vol. 85, Núm. 6, pp. 1333-1338

2012

  1. Factores asociados al abandono de tratamiento antituberculoso convencional en Perú

    Archivos de Bronconeumologia, Vol. 48, Núm. 5, pp. 150-155

2009

  1. Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor α therapy in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 5, pp. 751-756

2003

  1. Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer

    Cancer Chemotherapy and Pharmacology, Vol. 52, Núm. 3, pp. 247-252

1999

  1. Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin

    Cancer, Vol. 86, Núm. 8, pp. 1463-1469